Membranous nephropathy: Quo vadis?

被引:25
作者
Cattran, DC [1 ]
机构
[1] Toronto Gen Hosp, Univ Hlth Network, Toronto, ON M5G 1L7, Canada
关键词
glomerulonephritis; end-stage renal disease; proteinuria; creatinine levels;
D O I
10.1046/j.1523-1755.2002.00125.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:349 / 350
页数:2
相关论文
共 13 条
[1]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[2]   A CONTROLLED TRIAL OF CYCLOSPORINE IN PATIENTS WITH PROGRESSIVE MEMBRANOUS NEPHROPATHY [J].
CATTRAN, DC ;
GREENWOOD, C ;
RITCHIE, S ;
BERNSTEIN, K ;
CHURCHILL, DN ;
CLARK, WF ;
MORRIN, PA ;
LAVOIE, S .
KIDNEY INTERNATIONAL, 1995, 47 (04) :1130-1135
[3]   Validation of a predictive model of idiopathic membranous nephropathy: Its clinical and research implications [J].
Cattran, DC ;
Pei, Y ;
Greenwood, CMT ;
Ponticelli, C ;
Passerini, P ;
Honkanen, E .
KIDNEY INTERNATIONAL, 1997, 51 (03) :901-907
[4]   A RANDOMIZED CONTROLLED TRIAL OF PREDNISONE IN PATIENTS WITH IDIOPATHIC MEMBRANOUS NEPHROPATHY [J].
CATTRAN, DC ;
DELMORE, T ;
ROSCOE, J ;
COLE, E ;
CARDELLA, C ;
CHARRON, R ;
RITCHIE, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (04) :210-215
[5]  
COGGINS CH, 1979, NEW ENGL J MED, V301, P1301
[6]   TREATMENT OF PROGRESSIVE MEMBRANOUS GLOMERULOPATHY - A RANDOMIZED TRIAL COMPARING CYCLOPHOSPHAMIDE AND CORTICOSTEROIDS WITH CORTICOSTEROIDS ALONE [J].
FALK, RJ ;
HOGAN, SL ;
MULLER, KE ;
JENNETTE, JC .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (06) :438-445
[7]   Changing etiologies of unexplained adult nephrotic syndrome: A comparison of renal biopsy findings from 1976-1979 and 1995-1997 [J].
Haas, M ;
Meehan, SM ;
Karrison, TG ;
Spargo, BH .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (05) :621-631
[8]   Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes [J].
Lewis, EJ ;
Hunsicker, LG ;
Clarke, WR ;
Berl, T ;
Pohl, MA ;
Lewis, JB ;
Ritz, E ;
Atkins, RC ;
Rohde, R ;
Raz, I .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :851-860
[9]  
*NIH NAT I DIAB DI, 1999, US REN DAT SYST USRD
[10]   PREDICTING CHRONIC RENAL-INSUFFICIENCY IN IDIOPATHIC MEMBRANOUS GLOMERULONEPHRITIS [J].
PEI, Y ;
CATTRAN, D ;
GREENWOOD, C .
KIDNEY INTERNATIONAL, 1992, 42 (04) :960-966